FibroGen Inc
NASDAQ:KYNB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
FibroGen Inc
NASDAQ:KYNB
|
US |
|
Rentokil Initial PLC
LSE:RTO
|
UK |
|
M
|
Mckesson Corp
F:MCK
|
US |
|
Smaregi Inc
TSE:4431
|
JP |
|
B
|
Buckle Inc
F:BK2
|
US |
|
T
|
Tencent Holdings Ltd
DUS:NNN1
|
CN |
|
Brown-Forman Corp
NYSE:BF.B
|
US |
|
Lincoln National Corp
NYSE:LNC
|
US |
|
T
|
Trillion Energy International Inc
CNSX:TCF
|
CA |
|
A
|
Asahi Kasei Corp
F:ASAA
|
JP |
|
N
|
Nextera Energy Inc
F:FP3
|
US |
|
Abionyx Pharma SA
F:609
|
FR |
|
KDDI Corp
F:DIP
|
JP |
|
N
|
Novavax Inc
SWB:NVV1
|
US |
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
US |
|
N
|
NetApp Inc
XBER:NTA
|
US |
Multiples-Based Value
The Multiples-Based Value for
FibroGen Inc (KYNB) under the Base Case is hidden
USD.
Compared with the current market price of 6.99 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.